JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A2415 Acitretin

Target: RARs

Summary: Metabolite of etretinate

insoluble in EtOH; insoluble in H2O; ≥16.32 mg/mL
A1987 Ki16425
6 Citation

Target: LPA Receptors

Summary: LPA receptor antagonist

≥23.75 mg/mL
A1352 Zoledronic Acid

Target: Farnesyl Diphosphate Synthases

Summary: Potent nitrogen-containing bisphosphonates

insoluble in DMSO; insoluble in H2O; insoluble in EtOH
A1778 Vatalanib (PTK787) 2HCl

Target: VEGFR

Summary: Tyrosine kinase receptor inhibitor

≥21 mg/mL
A5926 Febuxostat

Summary: non-purine selective inhibitor of xanthine oxidase

insoluble in H2O; ≥15.55 mg/mL
A5755 MK-1775
4 Citation

Summary: Wee1 kinase inhibtor,potent and ATP-competitive

≥25.03 mg/mL
A1169 10058-F4

Summary: C-Myc-Max dimerization inhibitor

≥24.9 mg/mL
A2224 Stattic
14 Citation

Target: STAT

Summary: STAT3 inhibitor,small-molecule and potent

insoluble in H2O; insoluble in EtOH; ≥10.56 mg/mL
A2249 T0901317

Target: Liver X receptors (LXRs)

Summary: Liver X receptor agonist,potent and selective

≥24.05 mg/mL
A1173 AG-18

Summary: EGFR/PDGFR inhibitor